Major response to imatinib mesylate in KIT-mutated melanoma

F. Stephen Hodi; Philip Friedlander; Christopher L. Corless; Michael C. Heinrich; Suzanne Mac Rae; Andrea Kruse; Jyothi Jagannathan; Annick D. Van Den Abbeele; Elsa F. Velazquez; George D. Demetri; David E. Fisher

doi:10.1200/JCO.2007.14.0707

Major response to imatinib mesylate in KIT-mutated melanoma

F. Stephen Hodi, Philip Friedlander, Christopher L. Corless, Michael C. Heinrich, Suzanne Mac Rae, Andrea Kruse, Jyothi Jagannathan, Annick D. Van Den Abbeele, Elsa F. Velazquez, George D. Demetri, David E. Fisher

Knight Cancer Institute

Research output: Contribution to journal › Article

342 Scopus citations

Original language	English (US)
Pages (from-to)	2046-2051
Number of pages	6
Journal	Journal of Clinical Oncology
Volume	26
Issue number	12
DOIs	https://doi.org/10.1200/JCO.2007.14.0707
State	Published - Sep 15 2008

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2007.14.0707

Cite this

Hodi, F. S., Friedlander, P., Corless, C. L., Heinrich, M. C., Mac Rae, S., Kruse, A., Jagannathan, J., Van Den Abbeele, A. D., Velazquez, E. F., Demetri, G. D., & Fisher, D. E. (2008). Major response to imatinib mesylate in KIT-mutated melanoma. Journal of Clinical Oncology, 26(12), 2046-2051. https://doi.org/10.1200/JCO.2007.14.0707

Major response to imatinib mesylate in KIT-mutated melanoma. / Hodi, F. Stephen; Friedlander, Philip; Corless, Christopher L.; Heinrich, Michael C.; Mac Rae, Suzanne; Kruse, Andrea; Jagannathan, Jyothi; Van Den Abbeele, Annick D.; Velazquez, Elsa F.; Demetri, George D.; Fisher, David E.

In: Journal of Clinical Oncology, Vol. 26, No. 12, 15.09.2008, p. 2046-2051.

Research output: Contribution to journal › Article

Hodi, F. Stephen ; Friedlander, Philip ; Corless, Christopher L. ; Heinrich, Michael C. ; Mac Rae, Suzanne ; Kruse, Andrea ; Jagannathan, Jyothi ; Van Den Abbeele, Annick D. ; Velazquez, Elsa F. ; Demetri, George D. ; Fisher, David E. / Major response to imatinib mesylate in KIT-mutated melanoma. In: Journal of Clinical Oncology. 2008 ; Vol. 26, No. 12. pp. 2046-2051.

@article{46db0bed55a0424ea725e05686448ada,

title = "Major response to imatinib mesylate in KIT-mutated melanoma",

author = "Hodi, {F. Stephen} and Philip Friedlander and Corless, {Christopher L.} and Heinrich, {Michael C.} and {Mac Rae}, Suzanne and Andrea Kruse and Jyothi Jagannathan and {Van Den Abbeele}, {Annick D.} and Velazquez, {Elsa F.} and Demetri, {George D.} and Fisher, {David E.}",

year = "2008",

month = sep,

day = "15",

doi = "10.1200/JCO.2007.14.0707",

language = "English (US)",

volume = "26",

pages = "2046--2051",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "12",

}

TY - JOUR

T1 - Major response to imatinib mesylate in KIT-mutated melanoma

AU - Hodi, F. Stephen

AU - Friedlander, Philip

AU - Corless, Christopher L.

AU - Heinrich, Michael C.

AU - Mac Rae, Suzanne

AU - Kruse, Andrea

AU - Jagannathan, Jyothi

AU - Van Den Abbeele, Annick D.

AU - Velazquez, Elsa F.

AU - Demetri, George D.

AU - Fisher, David E.

PY - 2008/9/15

Y1 - 2008/9/15

UR - http://www.scopus.com/inward/record.url?scp=42949128595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949128595&partnerID=8YFLogxK

U2 - 10.1200/JCO.2007.14.0707

DO - 10.1200/JCO.2007.14.0707

M3 - Article

C2 - 18421059

AN - SCOPUS:42949128595

VL - 26

SP - 2046

EP - 2051

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 12

ER -